FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:807-808 September 22, 1994 Number 12 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

The first influenza vaccines were developed approximately 50 years ago by cultivating the virus in hens' eggs and inactivating it with formalin. Since influenza was viewed as a threat to military readiness, for many years thereafter the vaccines were regularly evaluated in randomized, controlled trials among military recruits; the vaccines were consistently found to be safe and at least 70 percent effective in preventing laboratory-confirmed clinical influenza¹. In spite of this good record and the fact that the current vaccine is more potent and has greater purity than the original, its value and appropriate use continue to be debated. . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Patriarca, P. A. (1994). A Randomized Controlled Trial of Influenza Vaccine in the Elderly: Scientific Scrutiny and Ethical Responsibility. JAMA 272: 1700-1701 [Abstract]